Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) CFO Cecilia Jones sold 2,932 shares of the company’s stock in a transaction that occurred on Tuesday, December 30th. The shares were sold at an average price of $27.09, for a total value of $79,427.88. Following the completion of the transaction, the chief financial officer directly owned […]

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) CEO Christopher Richard Anzalone sold 51,726 shares of Arrowhead Pharmaceuticals stock in a transaction that occurred on Monday, December 29th. The shares were sold at an average price of $69.13, for a total transaction of $3,575,818.38. Following the sale, the chief executive officer owned 3,805,926 shares in […]

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) CEO Christopher Richard Anzalone sold 13,445 shares of the company’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $67.66, for a total transaction of $909,688.70. Following the sale, the chief executive officer directly owned 3,818,512 shares of the […]